In the present pilot study, the feasibility of a site-of-care cervicovaginal self-sampling methodology for HPV-based screening was tested in 346 women residing in underserved rural areas of Northern Greece. These women provided self-collected cervicovaginal sample along with a study questionnaire. Following molecular testing, using the cobas HPV Test, Roche, HPV positive women, were referred to colposcopy and upon abnormal findings, to biopsy and treatment.
View Article and Find Full Text PDF